No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
75 (estimated)
Sponsor
Reset Medical and Wellness Center · Other
Who this trial is looking for
This trial is looking for Special Operations Veterans aged 18 and over with PTSD. Participants will receive a treatment called Bilateral Cervical Sympathetic Block, either on its own or combined with therapy, to see if it helps with their symptoms.
Are You a Good Fit for This Trial?
You may be able to join if
I am 18 years or older.
I have been diagnosed with PTSD.
I can provide informed consent and complete study procedures.
I speak English fluently.
I am a Special Operations Forces Veteran.
You may not be able to join if
I have received a cervical sympathetic block in the past 6 months.
I am currently in another clinical trial for PTSD or TBI.
I am experiencing an acute psychiatric crisis.
I have any medical conditions that would prevent me from receiving this treatment.
I cannot read or understand English well enough.
My PTSD symptoms are not severe enough at screening.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
This study prospectively evaluates the effects of Integrative Bilateral Cervical Sympathetic Block (BCSB) on trauma-related symptoms in Special Operations Veterans, comparing outcomes in those receiving BCSB alone versus BCSB combined with structured integrative therapy. Using standardized FDA-approved dosing, validated symptom measures, and strict safety criteria, the study aims to determine whet…
This study prospectively evaluates the effects of Integrative Bilateral Cervical Sympathetic Block (BCSB) on trauma-related symptoms in Special Operations Veterans, comparing outcomes in those receiving BCSB alone versus BCSB combined with structured integrative therapy. Using standardized FDA-approved dosing, validated symptom measures, and strict safety criteria, the study aims to determine whether this dual-level autonomic intervention improves PTSD-related and TBI-related symptoms, and whether pairing the procedure with therapy enhances durability and overall clinical benefit.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* 18 years or older
* PTSD (PCL Score of 33 or greater at baseline screening)
* Willing and able to provide informed consent and complete study procedures
* Fluent in English
* Special Operations Forces Veteran
Exclusion Criteria:
* Recent Sympathetic Block: Receipt of any cer…
Inclusion Criteria:
* 18 years or older
* PTSD (PCL Score of 33 or greater at baseline screening)
* Willing and able to provide informed consent and complete study procedures
* Fluent in English
* Special Operations Forces Veteran
Exclusion Criteria:
* Recent Sympathetic Block: Receipt of any cervical sympathetic block (including stellate ganglion block \[SGB\], dual sympathetic ganglion block \[DSGB\], or bilateral SGB/BCSB), whether unilateral or bilateral, within the past 6 months.
* Concurrent interventional clinical trial participation: Currently enrolled in another interventional clinical trial or receiving any experimental treatment targeting PTSD, TBI, or autonomic dysfunction during the study period
* Acute Psychiatric Instability: Currently experiencing acute psychiatric crisis requiring inpatient care, active suicidal or homicidal intent, or untreated mania, psychosis, or severe dissociation
* Medical Contraindications to BCSB: Any known anatomical abnormalities, bleeding disorders, allergy to local anesthetics, pregnancy, or comorbidities that represent a contraindication to receiving a cervical sympathetic block, per the treating physician's judgment.
* Language or communication barriers: Inability to read, speak, or understand English sufficiently to complete informed consent and study assessments
* Low PTSD Symptom Severity at Baseline: PCL-5 Score \< 33 at screening, indicating subclinical or minimal PTSD symptoms (Rationale: to ensure measurable clinical benefit and reduce floor effects)
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.
